Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Kamal Masarweh"'
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 14, p 4636 (2023)
Objectives: We aimed to evaluate the impact of respiratory symptoms and positive viral testing on the risk of serious bacterial infections (SBIs). Methods: A retrospective study was conducted that included infants (0–60 days) presenting with a feve
Externí odkaz:
https://doaj.org/article/273301a3e2d840008a508a5907e4c1c4
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 5, p 1918 (2023)
Pleuropulmonary blastoma (PPB) is a tumor occurring almost exclusively in infants and young children. This is the most common primary-lung malignancy in childhood. There is age-associated progression through a distinctive sequence of pathologic chang
Externí odkaz:
https://doaj.org/article/4201e50b0c774c7daf762bb18310f874
Autor:
Michal Gur, Yael Ben-David, Moneera Hanna, Anat Ilivitzki, Adi Weichhendler, Ronen Bar-Yoseph, Yazeed Toukan, Kamal Masarweh, Lea Bentur
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 15, p 3316 (2021)
Assessing disease severity in patients with cystic fibrosis (CF) is essential when directing therapies. Serum immunoglobulin G (IgG) levels increase with disease severity. Lung clearance index (LCI) is recognized as an outcome measure for CF clinical
Externí odkaz:
https://doaj.org/article/adb4138778cd458ba47388bf517bc875
Autor:
Michal Gur, Ronen Bar–Yoseph, Moneera Hanna, Dana Abboud, Zohar Keidar, Tala Palchan, Yazeed Toukan, Kamal Masarweh, Irit Alisha, Nehama Zuckerman‐Levin, Lea Bentur
Publikováno v:
Pediatric Pulmonology. 58:577-584
While the positive effect of Trikafta on cystic fibrosis (CF) pulmonary disease is well established, there is limited data about its effect on bone mineral density (BMD), body composition and exercise capacity.A pilot single center study. BMD and bod
Publikováno v:
Pediatric Pulmonology. 57:667-673
Following the opening of lockdown and relaxation of public health restrictions, an unusual surge of respiratory illness occurred during the spring/summer (Q2) 2021 season. We aimed to characterize this surge compared to previous years.Children discha
Autor:
Ronen Bar-Yoseph, Shalev Zuckerman, Kamal Masarweh, Yazeed Toukan, Vered Nir, Guy Gut, Moneera Hanna, Michal Gur, Lea Bentur
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 129:369-375
PURPOSE Relvar® (fluticasone furoate [FF]/vilanterol [VI]) is a once-daily inhaler with bronchodilator effect lasting 24 h. Our aim was to investigate the short- and long-term effects of FF/VI on exercise-induced asthma (EIA) in adolescents. METHODS
Autor:
Michal Gur, Nehama Zuckerman‐Levin, Kamal Masarweh, Moneera Hanna, Luca Laghi, Massimiliano Marazzato, Shir Levanon, Fahed Hakim, Ronen Bar–Yoseph, Michael Wilschanski, Lea Bentur
Publikováno v:
Pediatric pulmonology. 57(10)
Background and objectives Cystic fibrosis (CF)-related diabetes (CFRD) affects 50% of CF adults. Gut microbial imbalance (dysbiosis) aggravates their inflammatory response and contributes to insulin resistance (IR). We hypothesized that probiotics ma
Publikováno v:
Pediatrics International. 62:89-93
Background The increased and earlier use of prenatal ultrasound has facilitated the detection of congenital thoracic malformations (CTMs). Our Pediatric Pulmonology Institute follows an increasing number of patients with CTMs. Thus, we aimed to evalu
Autor:
L. Bentur, Moneera Hanna, Kamal Masarweh, Michal Gur, Adi Weichhendler, Ronen Bar-Yoseph, Yazeed Toukan, Anat Ilivitzki, Yael Ben-David
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 15
Journal of Clinical Medicine, Vol 10, Iss 3316, p 3316 (2021)
Volume 10
Issue 15
Journal of Clinical Medicine, Vol 10, Iss 3316, p 3316 (2021)
Assessing disease severity in patients with cystic fibrosis (CF) is essential when directing therapies. Serum immunoglobulin G (IgG) levels increase with disease severity. Lung clearance index (LCI) is recognized as an outcome measure for CF clinical
Publikováno v:
Pediatric pulmonologyREFERENCES. 56(12)